Global Nuclear Medicine-Radiopharmaceuticals Market Report 2019, Competitive Landscape, Trends and Opportunities

1 Nuclear Medicine-Radiopharmaceuticals Market Overview

1.1 Product Overview and Scope of Nuclear Medicine-Radiopharmaceuticals

1.2 Nuclear Medicine-Radiopharmaceuticals Segment by Type

1.2.1 Global Nuclear Medicine-Radiopharmaceuticals Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Diagnostic Medicine

1.2.3 The Market Profile of Therapeutic Medicine

1.3 Global Nuclear Medicine-Radiopharmaceuticals Segment by Application

1.3.1 Nuclear Medicine-Radiopharmaceuticals Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of SPECT

1.3.3 The Market Profile of PET

1.3.4 The Market Profile of Therapeutic

1.4 Global Nuclear Medicine-Radiopharmaceuticals Market by Region (2014-2026)

1.4.1 Global Nuclear Medicine-Radiopharmaceuticals Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3 Europe Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.1 Germany Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.2 UK Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.3 France Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.4 Italy Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.5 Spain Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.6 Russia Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.3.7 Poland Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.4 China Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.5 Japan Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.6 India Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.8 Central and South America Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Nuclear Medicine-Radiopharmaceuticals Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Nuclear Medicine-Radiopharmaceuticals (2014-2026)

1.5.1 Global Nuclear Medicine-Radiopharmaceuticals Revenue Status and Outlook (2014-2026)

1.5.2 Global Nuclear Medicine-Radiopharmaceuticals Production Status and Outlook (2014-2026)

2 Global Nuclear Medicine-Radiopharmaceuticals Market Landscape by Player

2.1 Global Nuclear Medicine-Radiopharmaceuticals Production and Share by Player (2014-2019)

2.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Player (2014-2019)

2.3 Global Nuclear Medicine-Radiopharmaceuticals Average Price by Player (2014-2019)

2.4 Nuclear Medicine-Radiopharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Nuclear Medicine-Radiopharmaceuticals Market Competitive Situation and Trends

2.5.1 Nuclear Medicine-Radiopharmaceuticals Market Concentration Rate

2.5.2 Nuclear Medicine-Radiopharmaceuticals Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Mallinckrodt Pharmaceuticals (Ireland)

3.1.1 Mallinckrodt Pharmaceuticals (Ireland) Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.1.3 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.1.4 Mallinckrodt Pharmaceuticals (Ireland) Business Overview

3.2 Peregrine Pharmaceuticals, Inc. (US)

3.2.1 Peregrine Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.2.3 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.2.4 Peregrine Pharmaceuticals, Inc. (US) Business Overview

3.3 Nordion, Inc. (Canada)

3.3.1 Nordion, Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.3.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.3.4 Nordion, Inc. (Canada) Business Overview

3.4 Alliance Medical (UK)

3.4.1 Alliance Medical (UK) Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.4.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.4.4 Alliance Medical (UK) Business Overview

3.5 Actinium Pharmaceuticals Inc (US)

3.5.1 Actinium Pharmaceuticals Inc (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.5.3 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.5.4 Actinium Pharmaceuticals Inc (US) Business Overview

3.6 Ion Beam Applications S.A (Belgium)

3.6.1 Ion Beam Applications S.A (Belgium) Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.6.3 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.6.4 Ion Beam Applications S.A (Belgium) Business Overview

3.7 Immunomedics, Inc. (US)

3.7.1 Immunomedics, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.7.3 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.7.4 Immunomedics, Inc. (US) Business Overview

3.8 Siemens Healthcare (US)

3.8.1 Siemens Healthcare (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.8.3 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.8.4 Siemens Healthcare (US) Business Overview

3.9 GE Healthcare (UK)

3.9.1 GE Healthcare (UK) Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.9.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.9.4 GE Healthcare (UK) Business Overview

3.10 Lantheus Medical Imaging Inc (US)

3.10.1 Lantheus Medical Imaging Inc (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.10.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.10.4 Lantheus Medical Imaging Inc (US) Business Overview

3.11 Medi-Radiopharma Ltd (Hungary)

3.11.1 Medi-Radiopharma Ltd (Hungary) Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.11.3 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.11.4 Medi-Radiopharma Ltd (Hungary) Business Overview

3.12 Cardinal Health, Inc (US)

3.12.1 Cardinal Health, Inc (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.12.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.12.4 Cardinal Health, Inc (US) Business Overview

3.13 Positron Corporation (US)

3.13.1 Positron Corporation (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.13.3 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.13.4 Positron Corporation (US) Business Overview

3.14 Bracco Imaging S.p.A (Italy)

3.14.1 Bracco Imaging S.p.A (Italy) Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.14.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.14.4 Bracco Imaging S.p.A (Italy) Business Overview

3.15 Jubilant Pharma (India)

3.15.1 Jubilant Pharma (India) Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.15.3 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.15.4 Jubilant Pharma (India) Business Overview

3.16 Avid Radiopharmaceuticals (US)

3.16.1 Avid Radiopharmaceuticals (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.16.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.16.4 Avid Radiopharmaceuticals (US) Business Overview

3.17 Bayer HealthCare Medical Care (US)

3.17.1 Bayer HealthCare Medical Care (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.17.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.17.4 Bayer HealthCare Medical Care (US) Business Overview

3.18 Advanced Medical Isotope Corporation (US)

3.18.1 Advanced Medical Isotope Corporation (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.18.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.18.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.18.4 Advanced Medical Isotope Corporation (US) Business Overview

3.19 Alseres Pharmaceuticals, Inc (US)

3.19.1 Alseres Pharmaceuticals, Inc (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.19.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.19.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.19.4 Alseres Pharmaceuticals, Inc (US) Business Overview

3.20 Triad Isotopes, Inc. (US)

3.20.1 Triad Isotopes, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Competitors

3.20.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification

3.20.3 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2014-2019)

3.20.4 Triad Isotopes, Inc. (US) Business Overview

4 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue (Value), Price Trend by Type

4.1 Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Type (2014-2019)

4.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)

4.3 Global Nuclear Medicine-Radiopharmaceuticals Price by Type (2014-2019)

4.4 Global Nuclear Medicine-Radiopharmaceuticals Production Growth Rate by Type (2014-2019)

4.4.1 Global Nuclear Medicine-Radiopharmaceuticals Production Growth Rate of Diagnostic Medicine (2014-2019)

4.4.2 Global Nuclear Medicine-Radiopharmaceuticals Production Growth Rate of Therapeutic Medicine (2014-2019)

5 Global Nuclear Medicine-Radiopharmaceuticals Market Analysis by Application

5.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2014-2019)

5.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Growth Rate of SPECT (2014-2019)

5.2.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption Growth Rate of PET (2014-2019)

5.2.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption Growth Rate of Therapeutic (2014-2019)

6 Global Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption by Region (2014-2019)

6.2 United States Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.3 Europe Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.4 China Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.5 Japan Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.6 India Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

7 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue (Value) by Region (2014-2019)

7.1 Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Region (2014-2019)

7.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

8 Nuclear Medicine-Radiopharmaceuticals Manufacturing Analysis

8.1 Nuclear Medicine-Radiopharmaceuticals Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis

9.2 Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Nuclear Medicine-Radiopharmaceuticals

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast (2019-2026)

11.1 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue Forecast (2019-2026)

11.1.1 Global Nuclear Medicine-Radiopharmaceuticals Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Nuclear Medicine-Radiopharmaceuticals Price and Trend Forecast (2019-2026)

11.2 Global Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Nuclear Medicine-Radiopharmaceuticals Product Picture

Table Global Nuclear Medicine-Radiopharmaceuticals Production and CAGR (%) Comparison by Type

Table Profile of Diagnostic Medicine

Table Profile of Therapeutic Medicine

Table Nuclear Medicine-Radiopharmaceuticals Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of SPECT

Table Profile of PET

Table Profile of Therapeutic

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure France Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Poland Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure China Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Japan Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure India Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Singapore Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Philippines Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Thailand Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Central and South America Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Brazil Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Mexico Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Colombia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Turkey Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Egypt Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure South Africa Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Nigeria Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2026)

Figure Global Nuclear Medicine-Radiopharmaceuticals Production Status and Outlook (2014-2026)

Table Global Nuclear Medicine-Radiopharmaceuticals Production by Player (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Production Share by Player (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Production Share by Player in 2018

Table Nuclear Medicine-Radiopharmaceuticals Revenue by Player (2014-2019)

Table Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Player (2014-2019)

Table Nuclear Medicine-Radiopharmaceuticals Price by Player (2014-2019)

Table Nuclear Medicine-Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Player

Table Nuclear Medicine-Radiopharmaceuticals Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Mallinckrodt Pharmaceuticals (Ireland) Profile

Table Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Peregrine Pharmaceuticals, Inc. (US) Profile

Table Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Nordion, Inc. (Canada) Profile

Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Alliance Medical (UK) Profile

Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Actinium Pharmaceuticals Inc (US) Profile

Table Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Ion Beam Applications S.A (Belgium) Profile

Table Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Immunomedics, Inc. (US) Profile

Table Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Siemens Healthcare (US) Profile

Table Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table GE Healthcare (UK) Profile

Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Lantheus Medical Imaging Inc (US) Profile

Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Medi-Radiopharma Ltd (Hungary) Profile

Table Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Cardinal Health, Inc (US) Profile

Table Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Positron Corporation (US) Profile

Table Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Bracco Imaging S.p.A (Italy) Profile

Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Jubilant Pharma (India) Profile

Table Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Avid Radiopharmaceuticals (US) Profile

Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Bayer HealthCare Medical Care (US) Profile

Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Advanced Medical Isotope Corporation (US) Profile

Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Alseres Pharmaceuticals, Inc (US) Profile

Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Triad Isotopes, Inc. (US) Profile

Table Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Production by Type (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Production Market Share by Type (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Production Market Share by Type in 2018

Table Global Nuclear Medicine-Radiopharmaceuticals Revenue by Type (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Type (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Type in 2018

Table Nuclear Medicine-Radiopharmaceuticals Price by Type (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Production Growth Rate of Diagnostic Medicine (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Production Growth Rate of Therapeutic Medicine (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption by Application (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption of SPECT (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption of PET (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption of Therapeutic (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption by Region (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Region (2014-2019)

Table United States Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Europe Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table China Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Japan Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table India Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Central and South America Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Production, Consumption, Export, Import (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Production by Region (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Production Market Share by Region (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Production Market Share by Region (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Production Market Share by Region in 2018

Table Global Nuclear Medicine-Radiopharmaceuticals Revenue by Region (2014-2019)

Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Region (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Region (2014-2019)

Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Region in 2018

Table Global Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table China Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table India Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Nuclear Medicine-Radiopharmaceuticals

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Nuclear Medicine-R